TY - JOUR
T1 - Human skeletal muscle cells derived from the orbicularis oculi have regenerative capacity for duchenne muscular dystrophy
AU - Yamanaka, Yukito
AU - Takenaka, Nana
AU - Sakurai, Hidetoshi
AU - Ueno, Morio
AU - Kinoshita, Shigeru
AU - Sotozono, Chie
AU - Sato, Takahiko
N1 - Funding Information:
This research has been supported by grants-in-aid from the Japan Agency for Medical Research and Development, Projects for Technology Development, Development of Cell Transplantation Methods for Refractory Muscle Diseases, AMED-CREST (AMED), the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (JST), and a grant from the Nakatomi Memorial Foundation. The authors are grateful for immortalized human myogenic Hu5/KD3 cells provided by Naohiro Hashimoto (National Center for Geriatrics and Gerontology, Obu, Japan).
Funding Information:
Funding: This research has been supported by grants-in-aid from the Japan Agency for Medical Research and Development, Projects for Technology Development, Development of Cell Transplantation Methods for Refractory Muscle Diseases, AMED-CREST (AMED), the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (JST), and a grant from the Nakatomi Memorial Foundation.
Publisher Copyright:
© 2019 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2019/7/2
Y1 - 2019/7/2
N2 - Skeletal muscle stem cells (MuSCs) have been proposed as suitable candidates for cell therapy in muscular disorders since they exhibit good capacity for myogenic regeneration. However, for better therapeutic outcomes, it is necessary to isolate human MuSCs from a suitable tissue source with high myogenic differentiation. In this context, we isolated CD56+CD82+ cells from the extra eyelid tissue of young and aged patients, and tested in vitro myogenic differentiation potential. In the current study, myogenic cells derived from extra eyelid tissue were characterized and compared with immortalized human myogenic cells. We found that myogenic cells derived from extra eyelid tissue proliferated and differentiated myofibers in vitro, and restored DYSTROPHIN or PAX7 expression after transplantation with these cells in mice with Duchenne muscular dystrophy. Thus, human myogenic cells derived from extra eyelid tissue including the orbicularis oculi might be good candidates for stem cell-based therapies for treating muscular diseases.
AB - Skeletal muscle stem cells (MuSCs) have been proposed as suitable candidates for cell therapy in muscular disorders since they exhibit good capacity for myogenic regeneration. However, for better therapeutic outcomes, it is necessary to isolate human MuSCs from a suitable tissue source with high myogenic differentiation. In this context, we isolated CD56+CD82+ cells from the extra eyelid tissue of young and aged patients, and tested in vitro myogenic differentiation potential. In the current study, myogenic cells derived from extra eyelid tissue were characterized and compared with immortalized human myogenic cells. We found that myogenic cells derived from extra eyelid tissue proliferated and differentiated myofibers in vitro, and restored DYSTROPHIN or PAX7 expression after transplantation with these cells in mice with Duchenne muscular dystrophy. Thus, human myogenic cells derived from extra eyelid tissue including the orbicularis oculi might be good candidates for stem cell-based therapies for treating muscular diseases.
UR - http://www.scopus.com/inward/record.url?scp=85070452860&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070452860&partnerID=8YFLogxK
U2 - 10.3390/ijms20143456
DO - 10.3390/ijms20143456
M3 - Article
C2 - 31337111
AN - SCOPUS:85070452860
SN - 1661-6596
VL - 20
JO - International journal of molecular sciences
JF - International journal of molecular sciences
IS - 14
M1 - 3456
ER -